CAS: 1609281-86-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AZD3264 REF: AN-AG00ABN0CAS: 1609281-86-8 | 98% | 458.00 €~1,074.00 € | Thu 02 May 24 |
 | AZD3264 REF: TM-T6771CAS: 1609281-86-8 | 99.42% | 52.00 €~1,569.00 € | Thu 09 May 24 |
 | AZD3264 REF: 3D-JPC28186CAS: 1609281-86-8 | Min. 95% | To inquire | Thu 13 Jun 24 |
Ref: AN-AG00ABN0
| 10mg | 458.00 € | |
| 25mg | 666.00 € | |
| 50mg | 1,074.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
AZD3264
CAS:1609281-86-8
AZD3264 is a new type IKK2 inhibitor.
Formula:
C21H23N5O4S
Purity:
99.42%
Color and Shape:
Solid
Molecular weight:
441.5
Ref: TM-T6771
| 1mg | 52.00 € | |
| 2mg | 69.00 € | |
| 5mg | 102.00 € | |
| 10mg | 157.00 € | |
| 25mg | 307.00 € | |
| 50mg | 491.00 € | |
| 100mg | 787.00 € | |
| 500mg | 1,569.00 € | |
| 1ml*10 (DMSO) | 112.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
AZD3264
CAS:1609281-86-8
AZD3264 is a matrix effect-based drug candidate that is currently being studied for its potential …
Formula:
C21H23N5O4S
Purity:
Min. 95%
Molecular weight:
441.5 g/mol
Ref: 3D-JPC28186
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024
